PRESS RELEASE published on 07/24/2025 at 14:40, 5 months 16 days ago Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris. La société de biotechnologie se concentre sur le développement de traitements thérapeutiques pour les maladies inflammatoires chroniques Euronext Paris Biotechnologie Abivax Traitements Thérapeutiques Maladies Inflammatoires
PRESS RELEASE published on 07/24/2025 at 14:40, 5 months 16 days ago Abivax annonce les modalités définitives de l’offre au public de 650M$ (554M€) d’American Depositary Shares Abivax annonce les modalités définitives de l’offre au public de 650M$ (554M€) d’American Depositary Shares pour financer le développement de thérapies biotechnologiques. Details de l'offre, stabilisation et prévisions financières Biotechnologie Abivax Ads Offre Publique Modalités Définitives
PRESS RELEASE published on 07/24/2025 at 14:40, 5 months 16 days ago Abivax announces trading resumption of its ordinary shares on Euronext Paris Abivax announces the trading resumption of its ordinary shares on Euronext Paris after a temporary halt for a public offering confirmation and pricing announcement Euronext Paris Abivax Public Offering Clinical-stage Biotechnology Trading Resumption
PRESS RELEASE published on 07/24/2025 at 14:40, 5 months 16 days ago Custodian Property Income REIT plc: Interim dividend Custodian Property Income REIT plc declares its first quarterly interim dividend for the financial year 2026 on 1.5 pence per share, enhancing income return from UK properties Dividend Custodian Property Income REIT Income Return UK Properties Financial Year 2026
PRESS RELEASE published on 07/24/2025 at 14:40, 5 months 16 days ago Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris. La société de biotechnologie se concentre sur le développement de traitements pour les maladies inflammatoires chroniques Euronext Paris Biotechnologie Abivax Négociations Traitements
PRESS RELEASE published on 07/24/2025 at 14:40, 5 months 16 days ago Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares Abivax announces pricing of $650M (€554M) public offering of American Depositary Shares to fund clinical development and working capital, with expected closing on July 28, 2025 Abivax Clinical Development Public Offering Pricing Closing
PRESS RELEASE published on 07/24/2025 at 14:40, 5 months 16 days ago Abivax annonce les modalités définitives de l’offre au public de 650M$ (554M€) d’American Depositary Shares Abivax annonce les modalités de son offre de 650M$ d'American Depositary Shares pour financer des développements cliniques. Stabilisation et options incluses Abivax Développement Clinique Offre Publique Stabilisation American Depositary Shares
PRESS RELEASE published on 07/24/2025 at 14:30, 5 months 16 days ago High level of approval at the Annual General Meeting - vote of confidence in the Netfonds AG's strategy Netfonds AG's Annual General Meeting sees high level of approval, demonstrating shareholders' confidence in company's strategy. Approval rate of 99.99% for balance sheet profit appropriation Annual General Meeting Shareholders Netfonds AG Strategy Approval
PRESS RELEASE published on 07/24/2025 at 14:21, 5 months 16 days ago EQS-Adhoc: CECONOMY AG: CECONOMY AG confirms advanced negotiations with JD.com CECONOMY AG confirms advanced negotiations with JD.com for possible public takeover. No binding agreements signed yet Acquisitions Negotiations Takeover CECONOMY AG JD.com
PRESS RELEASE published on 07/24/2025 at 14:11, 5 months 16 days ago EQS-Adhoc: FUTRUE GmbH submits request to implement squeeze-out of minority shareholders of PharmaSGP Holding SE FUTRUE GmbH requests squeeze-out of minority shareholders by PharmaSGP Holding SE as it holds over 95% shares. Valuation ongoing for cash compensation determination Squeeze-out Minority Shareholders Cash Compensation PharmaSGP Holding SE Futrue GmbH
Published on 01/09/2026 at 14:10, 4 hours 18 minutes ago Bocana Resources Corp. Provides Corporate Update to Various Projects Currently Underway
Published on 01/09/2026 at 13:40, 4 hours 48 minutes ago CANEX Metals Announces Significant Support for Its Offer to Purchase Shares of Gold Basin Resources, Extends Offer Until January 19, and Waives Minimum Tender Condition
Published on 01/09/2026 at 02:15, 16 hours 13 minutes ago BEACN Welcomes New Director Charles Huang and Closes Final Tranche of Non-Brokered Private Placement
Published on 01/09/2026 at 00:00, 18 hours 28 minutes ago LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP-1/GIP Platform
Published on 01/08/2026 at 22:00, 20 hours 28 minutes ago Alset AI Strengthens Market Presence with New Strategic Agreement
Published on 01/09/2026 at 18:05, 23 minutes ago TCL Earns Multiple CES 2026 Awards for Breakthrough Innovations Across TV, Mobile, and Smart Home Categories
Published on 01/09/2026 at 18:00, 28 minutes ago BOA CONCEPT: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ
Published on 01/09/2026 at 18:00, 28 minutes ago ALTHEORA: Résiliation du contrat de liquidité et bilan semestriel avec Gilbert Dupont
Published on 01/09/2026 at 17:39, 48 minutes ago Terms and Conditions of a Buy-Back Offer by the Company
Published on 01/09/2026 at 17:45, 43 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 01/09/2026 at 17:45, 43 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL